ethambutol

简明释义

英[eˈθæmbjʊˌtɒl]美[eθˈæmbjʊtɔl]

n. [药] 乙胺丁醇片（一种抗结核药）

英英释义

单词用法

同义词

反义词

例句

1.The prospective pilot study enrolled 24 patients with tuberculosis who underwent FDG-PET scans prior to receiving treatment with isoniazid, rifampicin, and ethambutol.

此前瞻性的研究纳入了24例结核患者，在抗结核药物异烟肼、利福平和乙胺丁醇治疗前行FDG-PET扫描。

2.The prospective pilot study enrolled 24 patients with tuberculosis who underwent FDG-PET scans prior to receiving treatment with isoniazid, rifampicin, and ethambutol.

此前瞻性的研究纳入了24例结核患者，在抗结核药物异烟肼、利福平和乙胺丁醇治疗前行FDG-PET扫描。

3.Each cases was conducted the patch test of Isoniazid, Rifampicin, Pyrazinamide, Ethambutol streptomycin.

对每例进行异烟肼、利福平、吡嗪酰胺、乙胺丁醇、链霉素的斑贴试验。

4.In addition, Pyrazinamide and Ethambutol are also given for the first two months of treatment.

此外，吡嗪酰胺和乙胺丁醇也给予首两个月的治疗。

5.The most common anti-TB medicines are isoniazid, rifampicin, pyrazinamide and ethambutol.

最常用的抗结核药品是异烟肼、利福平、吡嗪酰胺和乙胺丁醇。

6.The other two medicines are Ethambutol and Pyrazinamide.

其它两种药物是乙胺丁醇和吡嗪酰胺。

7.The doctor prescribed ethambutol to treat the patient's tuberculosis.

医生开了乙胺丁醇来治疗患者的结核病。

8.After a thorough examination, the physician decided that ethambutol was necessary for the treatment plan.

经过全面检查，医生决定在治疗方案中加入乙胺丁醇。

9.Patients taking ethambutol should be monitored for any vision changes.

服用乙胺丁醇的患者应监测视力变化。

10.The effectiveness of ethambutol can be impacted by the patient's adherence to the medication schedule.

患者遵循药物服用时间表的情况会影响乙胺丁醇的有效性。

11.Healthcare providers often recommend ethambutol as part of a multi-drug regimen.

医疗服务提供者通常建议将乙胺丁醇作为多药物方案的一部分。

作文

Ethambutol is an important medication used primarily in the treatment of tuberculosis (TB), a serious infectious disease that affects millions of people worldwide. It belongs to a class of drugs known as antimycobacterial agents, which specifically target mycobacteria, the bacteria responsible for TB. The significance of ethambutol (乙胺丁醇) in TB treatment cannot be overstated, as it is often used in combination with other medications to ensure effective eradication of the disease while minimizing the risk of drug resistance. The mechanism of action of ethambutol involves inhibiting the synthesis of the bacterial cell wall. This is crucial because the integrity of the cell wall is essential for the survival and replication of the bacteria. By disrupting this process, ethambutol effectively reduces the bacterial load in the body, allowing the immune system to better combat the infection. Typically, ethambutol is administered alongside other first-line anti-TB drugs such as isoniazid, rifampicin, and pyrazinamide, forming a comprehensive treatment regimen. One of the key advantages of ethambutol is its relatively low toxicity compared to some other anti-TB medications. However, like all drugs, it is not without side effects. The most notable potential adverse effect associated with ethambutol is optic neuritis, which can lead to vision changes or loss if not monitored closely. Therefore, regular eye examinations are recommended for patients undergoing treatment with ethambutol. This highlights the importance of patient education and adherence to prescribed monitoring protocols during TB treatment. The use of ethambutol has been especially crucial in the management of multidrug-resistant tuberculosis (MDR-TB). MDR-TB occurs when the bacteria develop resistance to at least isoniazid and rifampicin, the two most potent anti-TB drugs. In such cases, ethambutol becomes a vital component of the second-line treatment options available to healthcare providers. Its role in combination therapy helps to enhance the overall efficacy of treatment and improve outcomes for patients who otherwise might have limited options. In recent years, public health initiatives aimed at controlling and eliminating TB have underscored the importance of medications like ethambutol. Access to effective treatment is critical in reducing transmission rates and preventing the spread of resistant strains of the bacteria. As such, healthcare systems around the world are working to ensure that ethambutol and other essential TB medications are available to those in need. In conclusion, ethambutol (乙胺丁醇) is a cornerstone in the fight against tuberculosis, playing a vital role in both standard and multidrug-resistant treatment regimens. Its ability to inhibit mycobacterial growth while maintaining a favorable safety profile makes it an invaluable tool for healthcare professionals. As we continue to battle this global health challenge, the importance of ethambutol and its contributions to TB treatment will remain critical in our efforts to eradicate this disease and improve public health outcomes worldwide.

乙胺丁醇是一种重要的药物，主要用于治疗结核病（TB），这是一种严重的传染病，影响着全球数百万人。它属于抗分枝杆菌药物类，这类药物专门针对分枝杆菌，即导致结核病的细菌。ethambutol（乙胺丁醇）在结核病治疗中的重要性不容小觑，因为它通常与其他药物联合使用，以确保有效根除疾病，同时最小化耐药风险。 ethambutol的作用机制是抑制细菌细胞壁的合成。这一点至关重要，因为细胞壁的完整性对细菌的生存和复制至关重要。通过破坏这一过程，ethambutol有效减少体内的细菌负荷，使免疫系统能够更好地对抗感染。通常，ethambutol与其他一线抗结核药物如异烟肼、利福平和吡嗪酰胺联合使用，形成全面的治疗方案。 ethambutol的一个关键优势是其相对于其他一些抗结核药物的低毒性。然而，像所有药物一样，它并非没有副作用。与ethambutol相关的最显著潜在不良反应是视神经炎，这可能导致视力变化或丧失，如果不进行密切监测，将会造成后果。因此，建议接受ethambutol治疗的患者定期进行眼部检查。这突显了患者教育和遵循处方监测协议的重要性。 在多药耐药结核病（MDR-TB）的管理中，ethambutol的使用尤其关键。MDR-TB发生在细菌对至少异烟肼和利福平这两种最有效的抗结核药物产生耐药性时。在这种情况下，ethambutol成为医疗提供者可用的第二线治疗选择的重要组成部分。它在联合治疗中的作用有助于增强治疗的整体效果，并改善那些否则可能选择有限的患者的结果。 近年来，旨在控制和消除结核病的公共卫生倡议强调了像ethambutol这样的药物的重要性。获得有效治疗对降低传播率和防止耐药菌株的传播至关重要。因此，世界各地的医疗系统正在努力确保ethambutol和其他基本的抗结核药物能够供有需要的人使用。 总之，ethambutol（乙胺丁醇）是与结核病作斗争的基石，在标准和多药耐药治疗方案中发挥着至关重要的作用。它能够抑制分枝杆菌的生长，同时保持良好的安全性，使其成为医疗专业人员的宝贵工具。随着我们继续与这一全球健康挑战作斗争，ethambutol的重要性及其对结核病治疗的贡献将在我们消灭这种疾病和改善全球公共卫生成果的努力中继续保持关键地位。